DALLAS / Nov 19, 2024 / Business Wire / Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its participation in the upcoming BofA Securities 2024 Home Care Conference.
Enhabit’s President and Chief Executive Officer Barb Jacobsmeyer, incoming Chief Financial Officer Ryan Solomon, and Senior Vice President of Strategic Finance & Treasurer Jobie Williams will participate in a fireside chat on Tuesday, Dec. 10, at 9:00 a.m. EST. The fireside chat will be webcast live and available for replay at https://investors.ehab.com under the events and presentations link.
About Enhabit Home Health & Hospice
Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit's team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 256 home health locations and 112 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.
| Last Trade: | US$9.68 |
| Daily Change: | 0.08 0.83 |
| Daily Volume: | 489,536 |
| Market Cap: | US$489.900M |
November 05, 2025 August 06, 2025 May 07, 2025 November 06, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
